J. Allyson Hays

605 citations
4 papers · 82 indexed · h-index 3
Topics
Childhood Cancer Survivors' Quality of Life (3 papers)Acute Lymphoblastic Leukemia research (2 papers)Acute Myeloid Leukemia Research (1 paper)
Partner nations
United StatesGermany

In The Last Decade

J. Allyson Hays

4 papers receiving 80 citations

Peers

J. Allyson Hays
Comparison fields: 5 of 28
  • Hematology 57
  • Immunology 36
  • Infectious Diseases 28
  • Public Health, Environmental and Occupational Health 12
  • Molecular Biology 11
Replace Milena Kohn with:
Milena Kohn France
Margherita Oberti Italy
Gabriella Maioli Italy
Manuel Salgado Portugal
Colleen Timlin United States
Ibrahim Ghemlas Saudi Arabia
Maxi Wass Germany
Matthew L. Basiaga United States
Tounes Ledraa France
Clodagh Sweeney Ireland
J. Allyson Hays relative to Milena Kohn France Milena Kohn's profile →
Citations per field
00.5×1.5×1.8×
Milena Kohn · 1×
Citations per year

Countries citing papers authored by J. Allyson Hays

Since Specialization
Citations

This map shows the geographic impact of J. Allyson Hays's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Allyson Hays with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Allyson Hays more than expected).

Fields of papers citing papers by J. Allyson Hays

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Allyson Hays. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Allyson Hays. The network helps show where J. Allyson Hays may publish in the future.

Co-authorship network of co-authors of J. Allyson Hays

This figure shows the co-authorship network connecting the top 25 collaborators of J. Allyson Hays. A scholar is included among the top collaborators of J. Allyson Hays based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Allyson Hays. J. Allyson Hays is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 2
2 57
3 4
4 19

About J. Allyson Hays

J. Allyson Hays is a scholar working on Hematology, Pediatrics, Perinatology and Child Health and Speech and Hearing, having authored 4 papers that have together received 82 indexed citations. Recurring topics across this work include Childhood Cancer Survivors' Quality of Life (3 papers), Acute Lymphoblastic Leukemia research (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Hematology (57 citations), Immunology (36 citations) and Infectious Diseases (28 citations). J. Allyson Hays has collaborated with scholars based in United States and Germany. Frequent co-authors include Keith J. August, Erin Guest, Alan S. Gamis, Matt S. Zinter, Rafał Machowicz, Gritta Janka, Kai Lehmberg, Päivi Miettunen, Jan van Laar and Karin Beutel. Their work appears in journals such as Blood, Critical Care Medicine and Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026